BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10207567)

  • 1. Tuberculosis treatment practices in the era of protease inhibitors: a provider survey.
    Sundaram V; Driver CR; Munsiff SS
    AIDS; 1999 Jan; 13(1):149-50. PubMed ID: 10207567
    [No Abstract]   [Full Text] [Related]  

  • 2. Follow-up to management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis.
    Tseng A; Walmsley S
    Can Commun Dis Rep; 1998 Aug; 24(16):129-32. PubMed ID: 9727271
    [No Abstract]   [Full Text] [Related]  

  • 3. Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis. TB/HIV Advisory Committee.
    Can Commun Dis Rep; 1998 May; 24(10):77-80. PubMed ID: 9613030
    [No Abstract]   [Full Text] [Related]  

  • 4. New TB guidelines for persons with HIV.
    AIDS Treat News; 1998 Nov; (No 306):6. PubMed ID: 11365963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TB drugs interact adversely with protease inhibitors.
    AIDS Alert; 1996 Oct; 11(10):117-8. PubMed ID: 11363854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis-HIV-co-infected patients in resource-constrained settings.
    Gray A; Abdool Karim SS; Gengiah TN
    AIDS; 2006 Jan; 20(2):302-3. PubMed ID: 16511431
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis: 8. The disease in association with HIV infection.
    FitzGerald JM; Houston S
    CMAJ; 1999 Jul; 161(1):47-51. PubMed ID: 10420866
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of HIV-protease inhibitors on opportunistic parasites.
    Pozio E; Morales MA
    Trends Parasitol; 2005 Feb; 21(2):58-63. PubMed ID: 15664527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of AIDS survival in Spain: effect of the inclusion of pulmonary tuberculosis for case definition in the protease inhibitors era].
    del Amo Valero J; Díez Ruiz-Navarro M
    Rev Clin Esp; 1998 Aug; 198(8):526-8. PubMed ID: 9774884
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.
    Burman WJ; Jones BE
    Am J Respir Crit Care Med; 2001 Jul; 164(1):7-12. PubMed ID: 11435232
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of rifamycins in HIV-infected patients.
    Preboth M
    Am Fam Physician; 2000 Sep; 62(5):1189-90. PubMed ID: 10997538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Genital tuberculosis and HIV infection].
    de Vega T; Méndez MA; Olavarría V; Amasuno MA; Napal J
    An Med Interna; 2001 Jun; 18(6):339. PubMed ID: 11503586
    [No Abstract]   [Full Text] [Related]  

  • 14. Rethinking about the role of antiretroviral regimens for HIV-related chronic diarrhoea.
    Famularo G; De Simone C
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):445-6. PubMed ID: 9789151
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis among HIV-infected persons in Norway].
    Ormaasen V; Maeland A
    Tidsskr Nor Laegeforen; 2001 Nov; 121(29):3425-30. PubMed ID: 11826791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interaction advisory.
    AIDS Patient Care STDS; 1997 Apr; 11(2):102. PubMed ID: 11361753
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential drug interacations.
    Posit Aware; 1996; 7(2):14-5. PubMed ID: 11363359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HAART on natural history of AIDS-related opportunistic disorders.
    Sepkowitz KA
    Lancet; 1998 Jan; 351(9098):228-30. PubMed ID: 9457088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.